BACK TO TOP
KSE100
168,021.80
-1370.52
(-0.81%)
KSE100PR
50,758.07
-423.14
(-0.83%)
ALLSHR
101,556.93
-689.83
(-0.67%)
KSE30
49,991.48
-476.61
(-0.94%)
KMI30
238,953.79
-2154.95
(-0.89%)
BKTI
46,602.59
-389.71
(-0.83%)
OGTI
34,306.18
-182.74
(-0.53%)
KMIALLSHR
65,832.11
-413.38
(-0.62%)
PSXDIV20
76,852.77
-972.56
(-1.25%)
UPP9
59,746.08
-514.38
(-0.85%)
NITPGI
44,539.79
-340.67
(-0.76%)
NBPPGI
47,884.55
-516.45
(-1.07%)
MZNPI
29,841.55
-277.97
(-0.92%)
JSMFI
41,279.80
-469.28
(-1.12%)
ACI
21,454.25
-245.58
(-1.13%)
JSGBKTI
70,709.57
-990.82
(-1.38%)
HBLTTI
19,055.52
15-09-2026
20.39
(0.11%)
MII30
21,640.16
-195.32
(-0.89%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.71.61
-0.22
(-0.31%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Wed, Sep 16, 2026 3:47 PM
REG
DFC
CSF
ODL
Open
71.79
High
72.30
Low
70.70
Volume
624,098
CIRCUIT BREAKER
64.65 — 79.01
DAY RANGE
70.70 — 72.30
52-WEEK RANGE ^
68.81 — 103.10
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
71.83
VAR
12.00
HAIRCUT
15.00
P/E Ratio (TTM) **
14.89
1-Year Change * ^
-27.23%
YTD Change * ^
-15.35%
Last update: Wed, Sep 16, 2026 3:49 PM
Open
71.80
High
72.00
Low
71.00
Close
71.50
Change
-1.04%
LDCP
72.25
Volume
6,500
Total Trades
11
CIRCUIT BREAKER
65.03 — 79.48
DAY RANGE
71.00 — 72.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Wed, Sep 16, 2026 3:35 PM
Open
72.23
High
72.23
Low
72.23
Close
72.23
Change
-1.38%
LDCP
73.24
Volume
500
Total Trades
1
CIRCUIT BREAKER
65.92 — 80.56
DAY RANGE
72.23 — 72.23
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 30, 2026 3:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
74.11
Volume
0
Total Trades
0
CIRCUIT BREAKER
66.70 — 81.52
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 2, 2026 2:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
73.24
Volume
0
Total Trades
0
CIRCUIT BREAKER
65.92 — 80.56
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Jun 28, 2026 3:32 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
72.14
Volume
0
Total Trades
0
CIRCUIT BREAKER
64.93 — 79.35
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,360,106.53
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31 March 2026 View   PDF
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
DateTitleDocument
Aug 28, 2026Notice of Extraordinary General Meeting View   PDF
Jul 9, 2026Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 08 July 2026 View   PDF
Jul 9, 2026Minutes of Extraordinary General Meeting
REVOKED
View   PDF
Jul 1, 2026Board Meeting Other Than Financial Results View   PDF
Jun 15, 2026Notice of Extraordinary General Meeting View   PDF
DateTitleDocument
Aug 10, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 7, 2026Chief Financial Officer View   PDF
Jul 8, 2026Material Information View   PDF
May 21, 2026Material Information View   PDF
May 6, 2026Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,084,7464,332,5663,370,2473,341,108
Profit after Taxation275,415404,334203,691220,375
EPS1.211.770.890.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports